To assess feasibility, complications and efficacy of secondary surgical cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in a selected group of platinum-sensitive recurrent ovarian cancer patients.

Fagotti, A., Paris, I., Grimolizzi, F., Fanfani, F., Vizzielli, G., Naldini, A., Scambia, G., Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study, <<GYNECOLOGIC ONCOLOGY>>, 2009; 113 (3): 335-340. [doi:10.1016/j.ygyno.2009.03.004] [http://hdl.handle.net/10807/32520]

Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study

Fagotti, Anna;Paris, Ida;Grimolizzi, Filomena;Fanfani, F;Scambia, Giovanni
2009

Abstract

To assess feasibility, complications and efficacy of secondary surgical cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in a selected group of platinum-sensitive recurrent ovarian cancer patients.
2009
Inglese
Fagotti, A., Paris, I., Grimolizzi, F., Fanfani, F., Vizzielli, G., Naldini, A., Scambia, G., Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study, <<GYNECOLOGIC ONCOLOGY>>, 2009; 113 (3): 335-340. [doi:10.1016/j.ygyno.2009.03.004] [http://hdl.handle.net/10807/32520]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/32520
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact